This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Procter & Gamble (PG) Q3 Earnings & Sales Beat Estimates
by Zacks Equity Research
Procter & Gamble (PG) posts robust third-quarter fiscal 2019 results. Also, it raises sales forecast for fiscal 2019.
Here's What You Must Note Ahead of Nu Skin (NUS) Q1 Earnings
by Zacks Equity Research
Nu Skin's (NUS) is likely to benefit from effective marketing programs, gains from social media and a solid sales leaders' network. These factors are set to drive customer count in Q1.
Top Ranked Growth Stocks to Buy for April 23rd
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 23rd
Kimberly-Clark (KMB) Stock Up on Q1 Earnings & Sales Beat
by Zacks Equity Research
Kimberly-Clark's (KMB) top and bottom lines beat the Zacks Consensus Estimate in Q1. However, cost woes lingered.
Here's Why Archer Daniels' (ADM) Q1 Earnings May Decline Y/Y
by Zacks Equity Research
Archer Daniels (ADM) witnesses softness in its Carbohydrate Solutions segment, which is likely to weigh on its first-quarter 2019 results. However, its cost-saving efforts are encouraging.
Helen of Troy (HELE) to Post Q4 Earnings: Things Not So Rosy
by Zacks Equity Research
Helen of Troy (HELE) is expected to be hurt by soft Beauty unit sales, tariff impacts and adverse mix in Q4 earnings season. However, strength in Leadership Brands will aid the stock.
Top Ranked Growth Stocks to Buy for April 22nd
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, April 12th.
Top Ranked Growth Stocks to Buy for April 17th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 17th
Will Kimberly-Clark (KMB) Beat Estimates in Q1 Earnings?
by Zacks Equity Research
Kimberly-Clark's (KMB) Q1 earnings are likely to be hurt by escalated costs and foreign-currency headwinds. However, restructuring plans are likely to offer respite.
3 Reasons Why Growth Investors Shouldn't Overlook Church & Dwight (CHD)
by Zacks Equity Research
Church & Dwight (CHD) could produce exceptional returns because of its solid growth attributes.
Procter & Gamble (PG) Boosts Shareholder Value, Hikes Dividend
by Zacks Equity Research
Procter & Gamble (PG) retains a commitment to reward shareholders by raising quarterly dividend by 4% to 74.59 cents per share.
Church & Dwight (CHD) Up 20% in 6 Months: Will Momentum Stay?
by Zacks Equity Research
Church & Dwight (CHD) flaunts an impressive sales trend, owing to the strong Consumer International unit, focus on acquisitions and brand enhancement initiatives. However, margin woes remain.
Church & Dwight Buys FLAWLESS and FINISHING TOUCH Brands
by Zacks Equity Research
Church & Dwight (CHD) unveils the buyout of FLAWLESS and FINISHING TOUCH. These leading hair removal brands will be a part of the company's power brands portfolio.
Church & Dwight (CHD) Up 4.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Church & Dwight (CHD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Can Soap & Cleaning Materials Industry Players Balance Costs & Growth?
by Zacks Equity Research
The FMCG space continues its struggles against higher raw material and transportation costs. Meanwhile, product innovation, marketing initiatives and restructuring actions should aid growth.
Philip Morris (PM) Beats on Q4 Earnings, Revenues Down Y/Y
by Zacks Equity Research
Philip Morris' (PM) Q4 results reflect weakness in combustible and RRPs units. However, strong pricing is an upside.
Flowers Foods (FLO) Q4 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Flowers Foods' (FLO) Q4 results benefit from strong brands. However, high input cost is a deterrent.
Company News For Feb 6, 2019
by Zacks Equity Research
Companies In The News Are: CHD,LITE,BP,LEG
Church & Dwight (CHD) Q4 Earnings Miss by a Penny, Up Y/Y
by Zacks Equity Research
Church & Dwight (CHD) remains on track to retain its impressive organic sales growth trend in 2019, backed by its solid product launches and investments.
Church & Dwight (CHD) Q4 Earnings Lag Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of -1.72% and 0.75%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Clorox (CLX) Earnings Surpass Estimates in Q2, Sales Miss
by Zacks Equity Research
Clorox (CLX) retains forecasts for fiscal 2019, which should benefit from ongoing cost-savings plans.
Avon (AVP) Eyes Turnaround, Reduces Headcount and Inventory
by Zacks Equity Research
Avon (AVP) moves ahead with the 'Open Up' Avon strategy as it plans to reset operating structure by reducing inventory levels and Stock Keeping Units, alongside lowering global headcount.
Will Archer Daniels (ADM) Retain Earnings Beat Trend in Q4?
by Zacks Equity Research
Archer Daniels (ADM) gains from its strategic initiatives including portfolio management, cost-savings plan and the Readiness program.
Coca-Cola Completes Buyout of Nigeria's Dairy & Juice Maker
by Zacks Equity Research
Coca-Cola (KO) acquires full stake in Nigeria's dairy and juice maker, Chi Ltd. Notably, Chi's diversified portfolio should aid the company's expansion in new categories and strengthen its business in Africa.
Altria (MO) Q4 Earnings Beat, Strong Pricing Aids Revenues
by Zacks Equity Research
Altria's (MO) Q4 performance gains on improved pricing. However, shipment volume in the smokeable unit continued to decline.